Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Intuitive Surgical (ISRG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

Intuitive Surgical (ISRG) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

AbbVie

Exxon Mobil

If you want to invest in some new halal stocks, you know that finding companies compliant with Shariah law can be complicated.

These four halal, Shariah-compliant stocks are best buys after Eid al-Fitr

Hitachi Ltd

Symbotic Inc

While robotics has been transforming major industrial spaces for decades, the rise of artificial intelligence (AI) could create even more efficiencies in this burgeoning field. In particular, with the advent of novel AI technologies, robotics could enter a new era of growth.

Wall Street Favorites: 3 Robotics Stocks with Strong Buy Ratings for April 2024

Clearpoint Neuro Inc

Transmedics Group Inc

Many investors might overlook MedTech healthcare stocks as the next goldmine of the stock market, but these companies often demonstrate unlimited potential. Unlike their pharma counterparts, for example, MedTech healthcare stocks are often nimbler and more innovative.

The 3 Most Promising MedTech Stocks to Invest In Now

Intuitive Surgical (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Intuitive Surgical, Inc. (ISRG) Reports Next Week: Wall Street Expects Earnings Growth

UiPath

Robotics stocks are becoming favorites among investors looking to buy quality, undervalued picks this season, thanks to the emergence of generative AI in 2024. The sound of robotics is not music to everyone's ears — there is anxiety of what will happen to the job in these industries.

If You Can Only Buy One Robotics Stock in April, It Better Be One of These 3 Names

Testimonials by two physicians inspire a $10 per share price target hike. The robotic-assisted surgery specialist has established a strong position in its market.

Is Intuitive Surgical Stock Going to $430? 1 Wall Street Analyst Thinks So.

Duolingo

The education technology and surgical robotics markets are growing at an explosive pace. Duolingo is raking in users and profits.

2 Monster Growth Stocks to Buy in 2024 Before They Surge Even Higher

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $390.96, marking a +1.04% move from the previous day.

Why Intuitive Surgical, Inc. (ISRG) Outpaced the Stock Market Today

Cigna

Eli Lilly

PureCycle Technologies

Simplify Health Care ETF

Sarepta Therapeutics

The Simplify Health Care exchange-traded fund has grown to $136 million in assets in two and a half years. It is never easy for an actively managed fund to outperform its benchmark or a broad stock-market index, but Michael Taylor, the fund's lead manager, has done that so far.

Outperforming ETF manager names a potential ‘50-bagger' in the stock market

Allogene Therapeutics Inc

Air Products and Chemicals

Sendas Distribuidora SA

American Express

BYD Company Limited

BYD Co Ltd

Cooper-Standard Holdings

Camden Property

Dollar General

Delek US Hlds

EPR Properties

Graco

Guardant Health Inc

SPDR Gold Trust

Kennedy-Wilson Holdings

MicroStrategy Incorporated

Natera

Nu Holdings

Omega Healthcare Investors

Portillo's

PayPal

Rolls-Royce Holdings PLC

There were 24 new analysts in March 2024. Gold, Bitcoin, a Bitcoin proxy pair trade, preferred shares, and a SOTP thesis are all covered.

Showcasing Seeking Alpha's March 2024 New Analysts

Intuitive Surgical is a pioneer in robotic-assisted surgery. One analyst believes the stock will climb to $462, fueled by its latest da Vinci platform and pent-up demand.

Intuitive Surgical Stock Has 20% Upside, According to 1 Wall Street Analyst. Is the Stock a Buy Near Its All-Time High?

ABB Ltd

Kratos Defense & Security Solutions

AI led the stock market to unprecedented heights last year, beckoning interest in complementary technologies such as robotics. Thanks to game-changing advancements in AI and automation technology, the robotics space is evolving swiftly.

The 3 Most Undervalued Robotics Stocks to Buy in April 2024

Want retirement to come a few years earlier than you'd planned? Or are you ready to retire now, but want an extra set of eyes on your finances?

If You Invested $5000 In Intuitive Surgical 10 Years Ago, This Is How Rich You Would Be Today

Advanced Micro Devices

Salesforce

CrowdStrike

CyberArk Software

monday.com

Cloudflare

Uber

Meta Platforms and AMD are among several leading stocks finding support around the 10-week line, creating potential buying opportunities.

Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action

Robotics has the potential to transform various industries, particularly manufacturing and healthcare, by creating new opportunities for automation and efficiency. Older industries and newer ones will benefit from automation in one way or another.

The 3 Best Robotics Stocks to Buy in April 2024

NVIDIA

The U.S. economy is on a positive trajectory, fueled by robust consumer spending and business investments. With profits rising steadily, there's an encouraging trend of retaining employees, further supporting economic expansion.

The 3 Best Robotics Stocks to Buy in Q2 2024

HCA Healthcare

Novo Nordisk

UnitedHealth Group

Vertex Pharmaceuticals

These seven healthcare companies are industry and market leaders. They generally present excellent long-term prospects, too.

Meet The "Magnificent Seven" of Healthcare Stocks

Medtronic

Intuitive Surgical and Medtronic are using AI to improve their medical devices. Both healthcare giants have excellent prospects beyond this promising area.

2 Healthcare Artificial Intelligence (AI) Stocks That Could Be Smart Investment Bets

The robotic-assisted surgery system market could nearly double in size by 2029. Artificial intelligence may improve Intuitive's surgical systems and also boost demand for the business.

Is Intuitive Surgical Stock a Millionaire Maker?

Barron's published an article in February discussing cheap healthcare stocks to buy, noting comments from Janus Henderson Global Life Sciences (MUTF: JAGLX ) co-manager Andy Acker. “At one point in October [2023], we had 232 biotech companies trading below the levels of cash on their balance sheet,” Acker told Barron's.

3 Healthcare Stocks to Buy From 3 of the Best Actively Managed Funds

Intuitive Surgical is now approved to launch its latest surgical robot. The latest da Vinci surgical unit has key features that no competitor has.

1 New Reason to Buy Intuitive Surgical Stock and Hold Forever

Teradyne

Zebra Technologies

Investors looking to invest in the next best industry have probably considered artificial intelligence (AI) or quantum computing. However, these favorite robotics stocks have already transformed various industries, particularly manufacturing and healthcare, by creating new opportunities for automation and efficiency.

Wall Street's Favorite Robotics Stocks? 3 Names That Could Make You Filthy Rich

News for Intuitive Surgical Stock (ISRG)